Neuromedin S (Human)
| Catalog number: | MDP0787 |
| CAS Number: | 197151-46-5 |
| Sequence: | Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
| Amount: | 100 ug |
| Molecular Weight: | 3791.2 g/mol |
| Supplied as: | Powder |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20 C |
| WARNING: | For in vitro Research Use Only. NOT for use on humans or animals. |
| Grade: | Biotechnology grade. All products are highly pure. |
References
- Mori K, Miyazato M, Kangawa K. Neuromedin S: discovery and functions Results Probl Cell Differ. 2008;46:201-12.
- Novak CM. Neuromedin S and U Endocrinology. 2009 Jul;150(7):2985-7.
- Malendowicz LK, Rucinski M. Neuromedins NMU and NMS: An Updated Overview of Their Functions Front Endocrinol (Lausanne). 2021 Jul 1;12:713961.
- Gajjar S, Patel BM. Neuromedin: An insight into its types, receptors and therapeutic opportunities Pharmacol Rep. 2017 Jun;69(3):438-447.
- Mitchell JD, Maguire JJ, Kuc RE, Davenport AP. Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system Cardiovasc Res. 2009 Feb 1;81(2):353-61.
- Edelmann MR, Erny J, Guba W, Hierl M. Tritium Labeling of Neuromedin S by Conjugation with [(3)H]N-Succinimidyl Propionate ACS Omega. 2023 Jan 4;8(2):2367-2376.
- Teranishi H, Hanada R. Neuromedin U, a Key Molecule in Metabolic Disorders Int J Mol Sci. 2021 Apr 19;22(8):4238.
- Mitchell JD, Maguire JJ, Davenport AP. Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S Br J Pharmacol. 2009 Sep;158(1):87-103.
- Yoshida M, Miyazato M, Kangawa K. Orphan GPCRs and methods for identifying their ligands Methods Enzymol. 2012;514:33-44.
